Teva's 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy
TEL AVIV, Israel, May 13, 2025 /3BL/ - Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) published its 2024 Healthy Future Report, sharing actions to advance its sustainability strategy. Teva achieved or surpassed many of its targets, some ahead of schedule. This includes targets tied to sustainable finance instruments, which directly connect its progress in increasing access to medicines and minimizing environmental impact to the Company's financial success. Healthy Future is focused on topics most relevant to Teva's business, supporting the Company in advancing its purpose—we are all in for better health—and enhancing its resilience.
Healthy PeopleTeva launched two new access to medicines programs—one in El Salvador and a global emergency stockpile—for a total of nine, surpassing its target of eight programs by 2025. Through these nine programs, Teva donated ~18 million doses of medicine, worth $23 million, and provided 2.2 million doses at low cost, reaching 187,000 patients. Five programs also focus on health systems strengthening and capacity building and benefitted ~56,000 individuals.
Healthy PlanetTeva achieved a 29% reduction in absolute scope 1 and 2 greenhouse gas (GHG) emissions from 2019 levels, surpassing its target of 25% by 2025 ahead of schedule. Additionally, 73% of applicable Teva sites achieved safe discharge levels of antibiotics, minimizing environmental pollution and supporting public health. Through a new antimicrobial resistance capacity-building pilot program in Germany, the Company educated more than 65,000 healthcare professionals, leading to approximately 389,000 patient interactions about appropriate use of antibiotics.
Healthy BusinessOperating with integrity helps Teva mitigate risk and build trust with its stakeholders. More than 99% of employees were retrained on compliance and ethics and Teva's Code of Conduct, achieving its annual target and reinforcing a culture of accountability and ethical decision-making. 41% of significant suppliers were evaluated for sustainability performance, and 100% of high-risk third-party business partners were evaluated through Teva's Third-Party Due Diligence tool, ensuring responsible sourcing practices and reducing risks across its supply chain.
'Healthy Future is closely connected to our Pivot to Growth strategy, designed to support long-term growth and resilience' said Richard Francis, Teva's President and CEO. 'Our 2024 Healthy Future report shares how we're advancing the topics most closely tied to our business, strengthening our company while continuing to better health worldwide—to create the future we want to see.'
Teva received improved scores from rating organizations such as Sustainalytics, MSCI and EcoVadis, as well as awards and recognition for its programs and progress.
To learn more, read the full 2024 Healthy Future Report.Read the full 2024 Healthy Future Report Disclosures.
About TevaTeva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, Teva's commitment to bettering health has never wavered. Today, the company's global network of capabilities enables its 37,000 employees across 57 markets to advance health by developing medicines for the future while championing the production of generics and biologics. We are dedicated to addressing patients' needs, now and in the future. Moving forward together with science that treats, inspired by the people we serve. To learn more about how Teva is all in for better health, visit www.tevapharm.com.
Cautionary Note Regarding Forward-Looking StatementsThis Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. These forward-looking statements include statements concerning our plans, strategies, objectives, future performance and financial and operating targets, and any other information that is not historical information. Important factors that could cause or contribute to such differences include risks relating to: our ability to impact and effectively execute on our sustainability, social, economic, environment and governance related strategies and goals; environmental risks; failure to comply with applicable environmental laws, health and safety laws and regulations worldwide; our ability to select sustainability-related disclosure frameworks that seek to align with various reporting standards which may change from time to time; our ability to collect, measure and report sustainability information and metrics, which is subject to evolving reporting standards; our ability to satisfy the targets set forth in our sustainability-linked senior notes, our sustainability-linked revolving credit facility and in other sustainability-linked financing instruments that we may issue; the impact of sustainability issues and other environmental risks on our business; and consequences of climate change; our ability to successfully compete in the marketplace, including: that we are substantially dependent on our generic products; our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, to sustain and focus our portfolio of generics medicines, and to execute on our organizational transformation and to achieve expected cost savings; our significant indebtedness; compliance, regulatory and litigation matters, including: failure to comply with complex legal and regulatory environments; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the first quarter of 2025 and in our Annual Report on Form 10-K for the year ended December 31, 2024, including in the sections captioned 'Risk Factors' and 'Forward Looking Statements.' Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.
Teva Media Inquiries [email protected]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
33 minutes ago
- Associated Press
What to know about inspections of Iran's nuclear program by the IAEA ahead of a key board vote
VIENNA (AP) — Iran's nuclear program remains a top focus for inspectors from the International Atomic Energy Agency, particularly as any possible deal between Tehran and the United States over the program would likely rely on the agency long known as the United Nations' nuclear watchdog. This week, Western nations will push for a measure at the IAEA's Board of Governors censuring Iran over its noncompliance with inspectors, pushing the matter before the U.N. Security Council. Barring any deal with Washington, Iran then could face what's known as 'snapback' — the reimposition of all U.N. sanctions on it originally lifted by Tehran's 2015 nuclear deal with world powers, if one of its Western parties declares the Islamic Republic is out of compliance with it. All this sets the stage for a renewed confrontation with Iran as the Mideast remains inflamed by Israel's war on Hamas in the Gaza Strip. And the IAEA's work in any case will make the Vienna-based agency a key player. Here's more to know about the IAEA, its inspections of Iran and the deals — and dangers — at play. Atoms for peace The IAEA was created in 1957. The idea for it grew out of a 1953 speech given by U.S. President Dwight D. Eisenhower at the U.N., in which he urged the creation of an agency to monitor the world's nuclear stockpiles to ensure that 'the miraculous inventiveness of man shall not be dedicated to his death, but consecrated to his life.' Broadly speaking, the agency verifies the reported stockpiles of member nations. Those nations are divided into three categories. The vast majority are nations with so-called 'comprehensive safeguards agreements' with the IAEA, states without nuclear weapons that allow IAE monitoring over all nuclear material and activities. Then there's the 'voluntary offer agreements' with the world's original nuclear weapons states — China, France, Russia, the United Kingdom and the U.S. — typically for civilian sites. Finally, the IAEA has 'item-specific agreements' with India, Israel and Pakistan — nuclear-armed countries that haven't signed the Nuclear Nonproliferation Treaty. That treaty has countries agree not to build or obtain nuclear weapons. North Korea, which is also nuclear armed, said it has withdrawn from the treaty, though that's disputed by some experts. The collapse of Iran's 2015 nuclear deal Iran's 2015 nuclear deal with world powers, negotiated under then-President Barack Obama, allowed Iran to enrich uranium to 3.67% — enough to fuel a nuclear power plant but far below the threshold of 90% needed for weapons-grade uranium. It also drastically reduced Iran's stockpile of uranium, limited its use of centrifuges and relied on the IAEA to oversee Tehran's compliance through additional oversight. But President Donald Trump in his first term in 2018 unilaterally withdrew America from the accord, insisting it wasn't tough enough and didn't address Iran's missile program or its support for militant groups in the wider Mideast. That set in motion years of tensions, including attacks at sea and on land. Iran now enriches up to 60%, a short, technical step away from weapons-grade levels. It also has enough of a stockpile to build multiple nuclear bombs, should it choose to do so. Iran has long insisted its nuclear program is for peaceful purposes, but the IAEA, Western intelligence agencies and others say Tehran had an organized weapons program up until 2003. IAEA inspections and Iran Under the 2015 deal, Iran agreed to allow the IAEA even greater access to its nuclear program. That included permanently installing cameras and sensors at nuclear sites. Those cameras, inside of metal housings sprayed with a special blue paint that shows any attempt to tamper with it, took still images of sensitive sites. Other devices, known as online enrichment monitors, measured the uranium enrichment level at Iran's Natanz nuclear facility. The IAEA also regularly sent inspectors into Iranian sites to conduct surveys, sometimes collecting environmental samples with cotton clothes and swabs that would be tested at IAEA labs back in Austria. Others monitor Iranian sites via satellite images. In the years since Trump's 2018 decision, Iran has limited IAEA inspections and stopped the agency from accessing camera footage. It's also removed cameras. At one point, Iran accused an IAEA inspector of testing positive for explosive nitrates, something the agency disputed. The IAEA has engaged in years of negotiations with Iran to restore full access for its inspectors. While Tehran hasn't granted that, it also hasn't entirely thrown inspectors out. Analysts view this as part of Iran's wider strategy to use its nuclear program as a bargaining chip with the West. What happens next Iran and the U.S. have gone through five rounds of negotiations over a possible deal, with talks mediated by the sultanate of Oman. Iran appears poised to reject an American proposal over a deal this week, potentially as soon as Tuesday. Without a deal with the U.S., Iran's long-ailing economy could enter a freefall that could worsen the simmering unrest at home. Israel or the U.S. might carry out long-threatened airstrikes targeting Iranian nuclear facilities. Experts fear Tehran in response could decide to fully end its cooperation with the IAEA, abandon the the Nuclear Nonproliferation Treaty and rush toward a bomb. If a deal is reached — or at least a tentative understanding between the two sides — that likely will take the pressure off for an immediate military strike by the U.S. Gulf Arab states, which opposed Obama's negotiations with Iran in 2015, now welcome the talks under Trump. Any agreement would require the IAEA's inspectors to verify Iran's compliance. But Israel, which has struck at Iranian-backed militants across the region, remains a wildcard on what it could do. Last year, it carried out its first military airstrikes on Iran — and has warned it is willing to take action alone to target Tehran's program, like it has in the past in Iraq in 1981 or Syria in 2007. ___ Associated Press writer Stephanie Liechtenstein contributed to this report. ___ The Associated Press receives support for nuclear security coverage from the Carnegie Corporation of New York and Outrider Foundation. The AP is solely responsible for all content. ___ Additional AP coverage of the nuclear landscape:
CNN
3 hours ago
- CNN
China to make all hospitals offer epidurals to incentivize childbirth
China said that by the end of this year all tertiary level hospitals must offer epidural anesthesia during childbirth, a move it said would help promote a 'friendly childbearing environment' for women. Tertiary hospitals – those with more than 500 beds – must provide epidural anesthesia services by 2025 while secondary hospitals – those containing more than 100 beds – must provide the services by 2027, China's National Health Commission (NHC) said in a statement last week. Authorities are struggling to boost birth rates in the world's second largest economy after China's population fell for a third consecutive year in 2024 with experts warning the downturn will worsen in the coming years. Around 30% of pregnant women in China receive anesthesia to relieve pain during childbirth, compared with more than 70% in some developed countries, the official China Daily said. The World Health Organization recommends epidurals for healthy pregnant women requesting pain relief and it is widely utilized in many countries around the world, including France, where around 82% of pregnant women opt to have one, and in the United States and Canada where more than 67% do. The move will 'improve the comfort level and security of medical services' and 'further enhance people's sense of happiness and promote a friendly childbearing environment,' the NHC said. A growing number of provinces across China are also beginning to include childbirth anesthesia costs as part of their medical insurance schemes to encourage more women to have children. High childcare costs as well as job uncertainty and a slowing economy have discouraged many young Chinese from getting married and starting a family. In June, health authorities in China's southwestern Sichuan province proposed to extend marriage leave up to 25 days and maternity leave up to 150 days, to help create a 'fertility-friendly society.'
CBS News
5 hours ago
- CBS News
Minnesota Legislature votes to remove undocumented immigrant adults from state health program
A contentious proposal that will remove undocumented immigrant adults from a state health care coverage program cleared the Minnesota Legislature on Monday — a key part of the compromise in the divided Capitol to pass the next two-year state budget. The measure makes undocumented adults no longer eligible for MinnesotaCare by the end of this year, just months after the DFL priority took effect in January. It's on its way to Gov. Tim Walz's desk, and he's expected to sign it. There is a provision in another proposal that will withhold funding for the health department if he doesn't. The change was a sticking point during negotiations between Democrats and Republicans, for whom repealing that law was a top priority in the divided Legislature. GOP lawmakers are concerned about growing enrollment and the cost to the state in future years. "If California and Illinois can't make the numbers work, what makes us think Minnesota can? The question before us is simple: Will we continue down a path of fiscal recklessness or will we act now to protect Minnesota taxpayers," said Rep. Harry Niska, R-Ramsey. Meanwhile, the bill sparked fierce pushback and emotional testimony from DFL lawmakers who said the change will cause irreparable harm. Former DFL House Speaker Melissa Hortman, who negotiated the budget deal, was the sole Democrat to vote for it in the tied House chamber-despite her personal opposition-clearing the way for its passage. "This bill is cruel. It is inhumane. And it will cost real human, Minnesotan lives," said Rep. Jamie Long, DFL-Minneapolis. More than 20,000 undocumented immigrants are enrolled in MinnesotaCare, which is more than expected for the first four months of the year, and 24% of them are children under 18, according to data from the Minnesota Department of Human Services. The cost to the state is slightly more expensive than originally estimated for this period. From January through the end of April, paid claims totalled $3.9 million, DHS data showed, but a spokeswoman said it is too early to know if it would have been as costly in a few years as Republicans claimed. The House took up the bill first during the one-day special session that began Monday to wrap up the next two-year state budget, and debated it for four hours. There were demonstrators outside the chamber before they gaveled in Monday with signs that read, "health care cuts kill." The Senate followed suit later with all GOP votes plus four Democrats, including Senate Majority Leader Erin Murphy, DFL-St. Paul, who held back tears as she spoke about the bill. "We will regain coverage for people because we are compassionate people and that's what we do in Minnesota. I made an agreement. I gave my word. I will vote for this and it's among the most painful votes I've ever taken," she said. For three weeks, lawmakers worked largely behind closed doors to fine tune the bills that together will make up the roughly $66 billion state budget for the next two years. They gaveled in to begin on Monday for what they planned to be a one-day special session to end Tuesday morning. Passing the MinnesotaCare coverage rollback was the most contentious proposal on the to-do list, which includes 14 bills.
